FDA Approved: BREVITAL SODIUM — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for Brevital Sodium (methohexital sodium) from Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• BREVITAL SODIUM (METHOHEXITAL SODIUM)

Snippet

SUPPL AP for BREVITAL SODIUM (METHOHEXITAL SODIUM)